Epigenetic silencing of TGFBI confers resistance to trastuzumab in human breast cancer.
Palomeras S, Diaz-Lagares Á, Viñas G, Setien F, Ferreira HJ, Oliveras G, Crujeiras AB, Hernández A, Lum DH, Welm AL, Esteller M, Puig T.
Palomeras S, et al. Among authors: oliveras g.
Breast Cancer Res. 2019 Jul 5;21(1):79. doi: 10.1186/s13058-019-1160-x.
Breast Cancer Res. 2019.
PMID: 31277676
Free PMC article.